Top compounds associated with response to CD302


Feature Type Standardized
Nominal ANOVA
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.11 0.0006
mRNA XMD13-2 GDSC1000 pan-cancer AAC -0.11 0.0007
mRNA TAK-715 GDSC1000 pan-cancer AAC -0.11 0.0008
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA Sorafenib CCLE pan-cancer AAC 0.16 0.0008
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.11 0.001
mRNA ATRA GDSC1000 pan-cancer AAC 0.11 0.001
mRNA RDEA119 FIMM pan-cancer AAC 0.56 0.001
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.097 0.001
Download CSV